The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded UT Southwestern Medical Center more than $18.4 million for cancer research and faculty recruitment.
UNLV study examines firsthand accounts of new fathers’ experiences with PPD, how it differs from that of women, and how to best remove barriers they face in receiving diagnoses and treatment of the little-known phenomenon.
New research by scientists at the University of Nottingham suggests that environmental contaminants found in the home and diet have the same adverse effects on male fertility in both humans and in domestic dogs.
Scientists from Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified how prostate cancer transforms into a deadly treatment-resistant subtype following treatment with anti-androgen therapy. Their findings—which include the metabolic rewiring and the epigenetic alteration that drives this switch— reveal that an FDA-approved drug holds potential as a NEPC treatment. The research also uncovers new therapeutic avenues that could prevent this transformation from occurring. The study was published in Cancer Cell.
Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at MD Anderson
New research suggests that the relationship between physical and brain fitness varies in older adults by virtue of their sex. The study is published ahead of print in the Journal of Applied Physiology.
Investigators at Rutgers Cancer Institute of New Jersey have found that a surgical procedure, when used as a first-line therapy for a form of testicular cancer known as seminoma, is associated with favorable survival rates.
When normal cells grow, divide or do any job in the body, they do so in response to a whole slew of internal sensors that measure nutrients and energy supply, and environmental cues that inform what happens outside the cell.
Many men with low-risk prostate cancer who most likely previously would have undergone immediate surgery or radiation are now adopting a more conservative “active surveillance” strategy, according to an analysis of a new federal database by scientists from Dana-Farber Cancer Institute.
Current tools used to predict prostate cancer progression are generally subjective in nature, leading to differing interpretations among clinicians
In what they consider a surprise finding, Johns Hopkins Medicine researchers have demonstrated a key role for male sex hormone “signaling” in inducing—rather than suppressing—allergic lung inflammation in a mouse model of asthma.
To make it easier for patients to receive world-class cancer care, UC San Diego Health has added a new multidisciplinary cancer clinic in Hillcrest and expanded its infusion center for both oncology patients and others in need of infusion services.
A new $1.7 million grant from the National Cancer Institute will enable researchers at the University of Illinois at Chicago to study the fruit and its potential as a treatment for prostate cancer.
A recent study has found that a specific gene in cancerous prostate tumors indicates when patients are at high-risk for the cancer to spread, suggesting that targeting this gene can help patients live longer.
Manish Kohli, M.D., has joined Moffitt Cancer Center as the vice chair of the Department of Genitourinary Oncology. He also has an extensive research background, focusing on creating new ways to bring individualized care to patients.
People with cancer are more than four times more likely to commit suicide than people without cancer, according to Penn State College of Medicine researchers.
Alterações genéticas no câncer de próstata de baixo risco, diagnosticado por biópsia com agulha, podem identificar homens que são portadores de câncer nas glândulas prostáticas com risco maior, segundo descoberta feita pela Mayo Clinic. A pesquisa, publicada na edição de janeiro da Mayo Clinic Proceedings, descobriu pela primeira vez que alterações genéticas associadas ao câncer de próstata de risco intermediário e alto também podem estar presentes em alguns casos de câncer de próstata de baixo risco.
Un estudio de Mayo Clinic descubrió que las alteraciones genéticas en el cáncer de próstata de bajo riesgo diagnosticado mediante biopsia por aguja pueden identificar a los hombres que corren más riesgo de cáncer en la glándula prostática.
Northwestern Medicine received a $10 million gift to fund the creation of a new multidisciplinary institute dedicated to urologic cancers.
Multiple miscarriages may be linked to the poor quality of a man's sperm, suggests new research. The early-stage study, from scientists at Imperial College London, investigated the sperm quality of 50 men whose partners had suffered three or more consecutive miscarriages.
Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbor higher-risk cancer in their prostate glands, Mayo Clinic has discovered. The research, which is published in the January edition of Mayo Clinic Proceedings, found for the first time that genetic alterations associated with intermediate- and high-risk prostate cancer also may be present in some cases of low-risk prostate cancers.
The Department of Urology at the Mount Sinai Health System has partnered with the nonprofit organization Man Cave Health to launch a first-of-its-kind sports-themed resource center for men that will provide educational resources on prostate health.
A first-of-its-kind study indicates that male partners of women with recurrent pregnancy loss have reduced sperm quality caused by impaired reproductive hormone production and high oxidant levels. This research, published in the Men’s Health Issue of AACC’s Clinical Chemistry journal, could help more couples with recurrent pregnancy loss to conceive by leading to new treatments that improve male partners’ reproductive health.
Experts and research on important topics in the healthcare system
Cedars-Sinai Cancer drove major advances in cancer research in 2018. Among these was a study about a pancreatic cancer drug, Metavert, developed by Cedars-Sinai investigators to prevent the most common type of pancreatic cancer from growing and spreading. Other groundbreaking research this year focused on reducing health disparities, the latest treatment options for newly diagnosed melanoma patients, and a study outlining a new, more accurate system for assessing the severity of head and neck cancers and for predicting patient survival.
Traditionally, treatment for muscle-invasive bladder cancer is chemotherapy followed by the removal of the bladder. However, researchers have data suggesting that treatment consisting of limited surgery followed by chemotherapy and radiation is just as effective.
New research from Duke Health suggests men in their child-bearing years should consider how THC could impact their sperm and possibly the children they conceive during periods when they’ve been using the drug. Much like previous research that has shown tobacco smoke, pesticides, flame retardants and even obesity can alter sperm, the Duke research shows THC also affects epigenetics, triggering structural and regulatory changes in the DNA of users’ sperm.
A new study investigating prostate cancer deaths by race has found that African American men have twice the chance of dying from low-risk prostate cancer than men of other racial and ethnic groups, even after adjusting for socioeconomic status.
Of the 165,000 men in the U.S. expected to be diagnosed with prostate cancer this year, about half will have low-risk disease. Many of those patients will opt for active surveillance -- a process in which men with low-risk, slow-growing prostate cancer are regularly monitored to see if the cancer starts to grow and requires treatment.
A longer duration of infertility was associated with lower sperm count and other parameters of impaired sperm in a BJU International study of 1644 infertile men. Also, older age and higher body mass index were associated with a longer duration of infertility.
Researchers at the University of Illinois at Chicago have found that men with chronic kidney disease, or CKD, are more likely to experience disease progression and death when compared with women suffering from the same condition.
The most popular YouTube videos on prostate cancer often offer misleading or biased medical information that poses potential health risks to patients, an analysis of the social media platform shows.
A new study has identified a novel molecular driver of lethal prostate cancer, along with a molecule that could be used to attack it. The findings were made in laboratory mice. If confirmed in humans, they could lead to more effective ways to control certain aggressive types of prostate cancer, the second-leading cause of cancer death for men in the U.S.
Talking with young adults who have Type 1 diabetes about their fears could greatly impact overall quality of life.
Eating leafy greens, dark orange and red vegetables and berry fruits, and drinking orange juice may be associated with a lower risk of memory loss over time in men, according to a study published in the November 21, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.
In November, some men grow mustaches to bring attention to men’s health issues. It’s also a good time for young men to learn about testicular cancer, the cancer that is most likely to strike them in the prime of life.
New research published in JNCCN-Journal of the National Comprehensive Cancer Network found Latino men were 21% less likely to receive definitive treatment compared to non-Latino white men, with significant differences for younger patients, the uninsured, and those treated at NCI-designated centers.
Men who are neurotic or introverted are more likely to be distressed after their prostate cancer diagnosis, according to a new study by researchers at Tulane University.
A small clinical trial using gold nanoparticles that act as tumor-seeking missiles on a mission to remove prostate cancer has begun at The University of Texas Health Science Center at Houston (UTHealth). It is the first trial of its kind in the world.
A single protein regulates a battery of key genes inside developing sperm, according to a new study out of Case Western Reserve University School of Medicine. Scientists discovered the protein—called Dazl—controls a network of genes essential for developing sperm to replicate and survive. The findings, published in Cell Reports, could lay the groundwork for future research into therapies for infertile men.
At a time when more than half of male infertility cannot be explained by current methods, a new test developed by Androvia LifeSciences is able to measure male fertility. The proprietary Cap-Score Male Fertility Assay is based on research patented by the Travis lab at the Baker Institute for Animal Health and Cornell University’s College of Veterinary Medicine and was recently the subject of a study that appeared Sept. 24 in the journal Molecular Reproduction and Development.
Fight Colorectal Cancer (Fight CRC) has once again been selected by No-Shave November as one of the three recipients for all funds raised during the 2018 campaign.
The first report of a large international clinical trial shows that, for men who show signs of prostate cancer after surgical removal of their prostates, extending radiation therapy to the pelvic lymph nodes combined with adding short-term hormone therapy to standard treatment can extend the amount of time before their cancer spreads. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.
While popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new analysis of genetic data from a large prospective registry and clinical data from several randomized trials indicates that African-American patients may have comparatively higher cure rates when treated with radiation therapy. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Stereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with low- and intermediate-risk prostate cancer, according to a long-term, multi-institutional study. The study clears the way for patients who may wish to shorten their course of treatment without fear of increasing their risk for severe, adverse side effects. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Recent studies have linked development of type 2 diabetes and impaired metabolic health individuals to their parents’ poor diet, and there is increasing evidence that fathers play an important role in obesity and metabolic programming of their offspring.In a new study published today in the journal Diabetes, researchers at Joslin Diabetes Center have shown that paternal exercise has a significant impact on the metabolic health of their offspring well into adulthood.
Researchers have discovered a way to grow human stem cells destined to become mature sperm in an effort to provide fertility options later in life to males who are diagnosed with cancer and undergo chemotherapy and radiation as children.
Nearly a half-million cancer patients are treated with radiation therapy every year in the United States. Now, technologies developed in partnership with the Department of Energy's Thomas Jefferson National Accelerator Facility (Jefferson Lab) are helping to ensure that patients are receiving just what the doctor ordered. The technologies are featured in RadiaDyne’s OARtrac® system, which was cited as a Medical Device Engineering Breakthrough Award and as a 2018 R&D 100 award finalist by R&D Magazine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right